Suppr超能文献

英格兰耐多药结核病负担:以现患病例为重点。

Burden of multidrug-resistant tuberculosis in England: a focus on prevalent cases.

机构信息

Public Health England, London, UK, University College London, UK.

Public Health England, London, UK.

出版信息

Int J Tuberc Lung Dis. 2019 Jun 1;23(6):707-713. doi: 10.5588/ijtld.18.0399.

Abstract

SETTING The incidence of multidrug-resistant tuberculosis (MDR-TB) is routinely reported by the Public Health England, UK, but prevalence better represents burden. OBJECTIVE To estimate MDR-TB prevalence, and identify the factors associated with acquired resistance and unsuccessful outcomes in people managed by the health services. DESIGN We included notified MDR-TB cases prevalent between 2010 and 2014. Multivariable logistic regression was used to identify the factors associated with acquisition of resistance and unsuccessful outcomes. The social risk factors (SRFs) recorded were alcohol, drug misuse, homelessness and incarceration. RESULTS Between 2010 and 2014, there were 2.3-3.1 times more prevalent than incident cases each year, with an increasing prevalence-to-incidence ratio over time; 86% of prevalent cases were foreign-born, and 15% had an SRF. Overall, 11% of MDR-TB cases acquired resistance, including 18% of those with SRFs and 22% of UK-born MDR-TB cases acquired resistance. Half of the cases completed treatment by 24 months; those with SRFs, extensive drug resistance or acquired resistance were less likely to complete treatment. DISCUSSION The number of prevalent cases is higher than incident cases, and increases over time, so a focus on prevalent cases enables better planning for services to support patients. We recommend that additional support be provided for those at risk of acquiring resistance, including those with SRFs. .

摘要

背景 英国公共卫生署定期报告耐多药结核病(MDR-TB)的发病率,但患病率更能反映疾病负担。 目的 估计 MDR-TB 的患病率,并确定与卫生服务管理的患者获得耐药性和治疗失败相关的因素。 设计 我们纳入了 2010 年至 2014 年间报告的 MDR-TB 现患病例。采用多变量逻辑回归来确定与获得耐药性和治疗失败相关的因素。记录的社会风险因素(SRFs)包括酒精、药物滥用、无家可归和监禁。 结果 与新发病例相比,2010 年至 2014 年间每年的现患病例多 2.3-3.1 倍,且随着时间的推移,患病率与发病率的比值呈上升趋势;86%的现患病例为外国出生,15%有 SRFs。总体而言,11%的 MDR-TB 病例发生了耐药,其中有 SRFs 的病例耐药率为 18%,英国出生的 MDR-TB 病例耐药率为 22%。所有 MDR-TB 病例中有一半在 24 个月内完成治疗;有 SRFs、广泛耐药或获得耐药的病例完成治疗的可能性较低。 讨论 现患病例的数量高于新发病例,且随着时间的推移而增加,因此关注现患病例能够更好地规划服务以支持患者。我们建议为那些有耐药风险的患者,包括有 SRFs 的患者,提供额外的支持。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验